137 related articles for article (PubMed ID: 30690821)
1. Trends in hepatitis B prevalence and associated risk factors among Indigenous and non-Indigenous prison entrants in Australia, 2004 to 2013.
Coles T; Simpson P; Saulo D; Kaldor J; Richards A; Levy M; Wake C; Siddall DA; Harrod ME; Kariminia A; Butler T
Aust N Z J Public Health; 2019 Jun; 43(3):236-240. PubMed ID: 30690821
[TBL] [Abstract][Full Text] [Related]
2. Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners - 2004, 2007, 2010.
Reekie JM; Levy MH; Richards AH; Wake CJ; Siddall DA; Beasley HM; Kumar S; Butler TG
Med J Aust; 2014 Mar; 200(5):277-80. PubMed ID: 24641153
[TBL] [Abstract][Full Text] [Related]
3. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
Butler T; Boonwaat L; Hailstone S; Falconer T; Lems P; Ginley T; Read V; Smith N; Levy M; Dore G; Kaldor J
Aust N Z J Public Health; 2007 Feb; 31(1):44-50. PubMed ID: 17333608
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey.
Long J; Allwright S; Barry J; Reynolds SR; Thornton L; Bradley F; Parry JV
BMJ; 2001 Nov; 323(7323):1209-13. PubMed ID: 11719410
[TBL] [Abstract][Full Text] [Related]
5. Spread of bloodborne viruses among Australian prison entrants.
Crofts N; Stewart T; Hearne P; Ping XY; Breshkin AM; Locarnini SA
BMJ; 1995 Feb; 310(6975):285-8. PubMed ID: 7866168
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B and Hepatitis C in prisons: a prevalence study.
Kose S; Adar P; Gozaydin A; Kuzucu L; Akkoclu G
Int J Prison Health; 2019 Jun; 15(2):162-167. PubMed ID: 31172859
[TBL] [Abstract][Full Text] [Related]
7. A cross-sectional study of susceptibility to vaccine-preventable diseases among prison entrants in New South Wales.
Larney S; Monkley DL; Indig D; Hampton SE
Med J Aust; 2013 Apr; 198(7):376-9. PubMed ID: 23581958
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L
Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland's largest pre-trial prison.
Gétaz L; Casillas A; Siegrist CA; Chappuis F; Togni G; Tran NT; Baggio S; Negro F; Gaspoz JM; Wolff H
J Glob Health; 2018 Dec; 8(2):020407. PubMed ID: 30140433
[TBL] [Abstract][Full Text] [Related]
10. Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs.
Palmateer NE; Goldberg DJ; Munro A; Taylor A; Yeung A; Wallace LA; Mitchell A; Shepherd SJ; Gunson RN; Aitken C; Hutchinson SJ
Addiction; 2018 Jan; 113(1):80-90. PubMed ID: 28710874
[TBL] [Abstract][Full Text] [Related]
11. Drug and alcohol use and treatment for Australian Indigenous and non-Indigenous prisoners: demand reduction strategies.
Dolan K; Rodas A; Bode A
Int J Prison Health; 2015; 11(1):30-8. PubMed ID: 25751705
[TBL] [Abstract][Full Text] [Related]
12. Prison health and public health responses at a regional prison in Western Australia.
Gilles M; Swingler E; Craven C; Larson A
Aust N Z J Public Health; 2008 Dec; 32(6):549-53. PubMed ID: 19076747
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of and risk factors for Human Immunodeficiency Virus (HIV) infection in entrants and residents of an Ethiopian prison.
Sahle ET; Amogne W; Manyazewal T; Blumenthal J; Jain S; Sun S; Young J; Ellorin E; Woldeamanuel H; Teferra L; Feleke B; Vandenberg O; Rey Z; Briggs-Hagen M; Haubrich R; McCutchan JA
PLoS One; 2023; 18(2):e0271666. PubMed ID: 36758059
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of hepatitis B and associated factors among inmates: a cross sectional study in the Douala New Bell Prison, Cameroon.
Kowo MP; Andoulo FA; Sizimboue DT; Ndam AWN; Ngek LT; Kouanfack C; Leundji H; Djanteng R; Ondo BE; Torimiro JN; Ndam EN; Njoya O
Pan Afr Med J; 2021; 38():355. PubMed ID: 34367434
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities.
Solomon L; Flynn C; Muck K; Vertefeuille J
J Urban Health; 2004 Mar; 81(1):25-37. PubMed ID: 15047781
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B immunity in Australia: a comparison of national and prisoner population serosurveys.
Gidding HF; Mahajan D; Reekie J; Lloyd AR; Dwyer DE; Butler T
Epidemiol Infect; 2015 Oct; 143(13):2813-21. PubMed ID: 25600771
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis B and hepatitis C infections and their relationship to injectable drug use in a cohort of Sri Lankan prison inmates.
Niriella MA; Hapangama A; Luke HP; Pathmeswaran A; Kuruppuarachchi KA; de Silva HJ
Ceylon Med J; 2015 Mar; 60(1):18-20. PubMed ID: 25804913
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)].
Michault A; Faulques B; Sevadjan B; Troalen D; Marais A; Barau G
Bull Soc Pathol Exot; 2000 Feb; 93(1):34-40. PubMed ID: 10774493
[TBL] [Abstract][Full Text] [Related]
19. HIV prevalence at reception into Australian prisons, 1991-1997.
McDonald AM; Ryan JW; Brown PR; Manners CJ; Falconer AD; Kinnear RC; Harvey WJ; Hearne PR; Banaszczyk M; Kaldor JM
Med J Aust; 1999 Jul; 171(1):18-21. PubMed ID: 10451666
[TBL] [Abstract][Full Text] [Related]
20. Assessment of cardiovascular disease risk factors and diabetes mellitus in Australian prisons: is the prisoner population unhealthier than the rest of the Australian population?
D'Souza RM; Butler T; Petrovsky N
Aust N Z J Public Health; 2005 Aug; 29(4):318-23. PubMed ID: 16222927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
